UK: How £300million was squandered on swine flu jabs that we didn't need

The World Health Organisation stands accused of announcing 'a false pandemic' in June last year.
Critics claim the drug firms manipulated the WHO into downgrading its definition of a pandemic so they could cash in.
In all, the companies behind the vaccines and anti-virals will pick up an estimated £4billion windfall from swine flu.
GlaxoSmithKline has revealed sales of its H1N1 vaccine reached £835million in the fourth quarter of last year.
In the same period, Novartis notched up vaccine sales of more than £800million, the vast majority from H1N1 sales.
Swiss drugs firm Roche reported profits up 14 per cent to £8.89billion last year, helped by sales of Tamiflu.
These companies vehemently deny having influenced the way in which the swine flu pandemic was managed